Vahe Grigoryan

YSMU, books, music, art, Հայաստան❤💙🧡

[Nara @nmatini]

Are we still questioning who provided #Azerbaijan with white phosphores which they used to burn forests and hundreds of our teenage conscripts during the 2020 #NagornoKarabakh war…

[Vahe Grigoryan @vaheedgari]

@amalsargsyan @YJanjigianMD @FilippoPietran4 @KlempnerSam @MSKCancerCenter @ImmoncInstitute So proud @amalsargsyan 🥹

[OncoDaily @oncodaily]

🎗️ OncoDaily Cervical Cancer Summit: 𝗛𝗼𝘄 𝗜 𝗧𝗿𝗲𝗮𝘁 𝗖𝗲𝗿𝘃𝗶𝗰𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗶𝗻 𝟮𝟬𝟮𝟲

Join us on 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟮𝟰, 2025, during 𝗖𝗲𝗿𝘃𝗶𝗰𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, for a global virtual summit bringing together leading experts to discuss how cervical cancer is treated today—and where care is heading next.

🎓 Real-world insights from All continents, specialists across Europe, Asia, South and North America, Africa, Australia all in one day.
🖥️ Format: Virtual Summit
🕘 Time: program starts 10am EST
📝 Registration: https://t.co/OT0x8FQGed

Let’s shape the future of cervical cancer care—together.
#CervicalCancer #CervicalCancerAwarenessMonth #OncoDaily #GynecologicOncology #CancerEducation #GlobalOncology #VirtualSummit

[OncoDaily @oncodaily]

How much time do you spend filtering through headlines to find the insights that actually impact your practice or research? We think 𝗶𝘁'𝘀 𝘁𝗶𝗺𝗲 𝗳𝗼𝗿 𝗮 𝗰𝗵𝗮𝗻𝗴𝗲. Time for something......

𝘊𝘰𝘮𝘪𝘯𝘨 𝘚𝘰𝘰𝘯

[OncoDaily GI @OncoDailyGI]

In this new episode of OncoDaily TV, host @ellenakaln talks with Dr. @aberkenblit , Chief Scientific & Medical Officer at @PanCAN about the future of pancreatic cancer care.

• Pancreatic cancer: 13% 5-year survival
• >90% RAS mutations — first Phase 3 RAS inhibitor trial reads out in 2026
• SPARK dataset (700+ pts) shaping precision medicine
• Early detection: family/genetics, pancreatitis, cysts, smoking, obesity, alcohol
• New-onset diabetes >50 + weight loss = major red flag
• PanCAN Patient Services + Clinical Trial Finder supporting patients & clinicians

🎥 Full episode: https://t.co/irPrALB2Vy

[OncoDaily GI @OncoDailyGI]

🎙 Dr. @RobinL_Jones shares ESMO updates on advanced GIST: ctDNA-guided trials; bezuclastinib+sunitinib, KIT exon 11+17/18 → ripretinib vs sunitinib; new agents IDRX-42, NB-003, DCC-3000; early signals for FOG-001 & B7-H3 in sarcoma. Watch https://t.co/P1atTfpQJD
@oncodaily

[OncoDaily @oncodaily]

BREAKING: U.S. walkout derails #G20 Health Ministers’ consensus in South Africa.

https://t.co/FZ3H5BaUNK

#GlobalHealthDiplomacy #HealthSecurity #G20Summit #PandemicResponse #HealthEquity #HealthForAll #G20

[CancerWorld @CancerWorldmag]

📣📣📣 CancerWorld Issue #109 (November) is live!

Where #leadership, #legacy, and #discovery meet the future of cancer care.

📌 This month’s issue features:

👑 Leadership & Humanity
In one of our cover stories HRH Princess Ghida Talal (@GhidaTalal) of Jordan shares how personal tragedy transformed into a lifelong mission to ensure equitable cancer care across the #Arab world.

🏛️ Legacy & Education
In our next cover story we revisit the visionary work of Prof. Umberto Veronesi, whose founding of the European School of Oncology (@ESOncology) nearly 50 years ago cemented the idea that learning to care is as essential as learning to cure.

🇪🇺 Policy & Prevention
MEP Tilly Metz (@MetzTilly) outlines the pillars of effective #CancerPolicy; prevent, treat, support, and the pressing need for #equity, #EnvironmentalHealth, and #HPV elimination across Europe.

🔬 Innovation & Science
– New oral microbiome findings that may one day enable early pancreatic cancer detection
– #AI models from @lunduniversity that could spare up to 40% of breast cancer patients unnecessary axillary surgery
– Insights from Amil Družić (@amil__dr) on how AI amplifies, not replaces, #oncologists
– Prof. Ludmil Alexandrov’s (@alexandrov_lud) groundbreaking work mapping mutational signatures to uncover cancer’s origins

🌱 Survivorship & Global Equity
– Fertility preservation breakthroughs at the Uganda Cancer Institute (@UgandaCancerInst)
– The extraordinary advocacy of Shrenik Shah, who found a new voice after losing his natural one
– A deep dive into workplace discrimination and the ongoing fight for the “#RightToBeForgotten”

Across continents and disciplines, these stories remind us that progress in oncology isn’t measured only in survival rates, but in dignity, equity, innovation, and the lives restored along the way.

👉 Read the full issue here: https://t.co/iaMO7C6u5W

Let us know which story resonates most with you.

@OncoDaily, @KHCFKHCC , @khcfusa, @Europarl_EN, @cancerleagues, @Artera_AI, @OpenAI, @EuropeanCancer

#CancerWorld #Oncology #CancerCare #CancerPolicy #CancerResearch #InnovationInHealthcare #LeadershipInHealth #AIinOncology #GlobalHealth #Survivorship #MedicalEducation #HealthEquity

[Gevorg Tamamyan @GevTamamyan]

It is a great honor to be named a Fellow of the American Society of Clinical Oncology (FASCO) — a recognition bestowed upon ASCO members who have shown extraordinary dedication through their voluntary efforts to benefit the Society, the specialty of oncology, and, most importantly, the patients we serve.

Years ago, when I first set foot at ASCO’s Annual Meeting — when all of Chicago was alive with the movement of nearly fifty thousand oncologists and members from around the world — I remember watching, in awe, as the world’s leading experts, whose names I had only read in books, were called to the stage to receive the title of FASCO. I could never have imagined that one day...

What can I say — I am deeply grateful to everyone who, in one way or another, directly or indirectly, has helped make this day possible 😊
It is, indeed, a great honor — and an even greater responsibility.

@ASCO @ConquerCancerFd @oncodaily

[OncoDaily @oncodaily]

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

@saak_ovsepian @ErulEnes

https://t.co/gOYg7aeDja

#OncoDaily #Oncology #Cancer #Health #Medicine #OncoDailyMedicalJournal #MedX

[OncoDaily @oncodaily]

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

@MyelomaOslo @MShahait @b_stefanovska

https://t.co/UgAav8eSLK

#OncoDaily #Oncology #Cancer #Health #Medicine #OncoDailyMedicalJournal #MedX

[OncoDaily @oncodaily]

💡 Oncogrants of the Week: 10 Competitive Funding Opportunities for Cancer Researchers and Clinicians 🌟

1️⃣ Jeffrey Pride Foundation Correlative Biology Awards – $100K (1 yr) | Projects in ALL, AML, Hodgkin and Non-Hodgkin lymphoma.
2️⃣ Radiation Oncology Institute RFP – Up to $100K (2 yrs) | Optimizing radiation and immunotherapy combinations.
3️⃣ ASTRO–PCF Young Investigator Award – $225K (3 yrs) | Advancing prostate cancer research in radiation oncology.
4️⃣ ASTRO–AAPM Seed Grant – $50K (1 yr) | Physics-focused projects by residents and postdocs.
5️⃣ ASTRO–LUNGevity Seed Grant – $50K (1 yr) | Research in lung cancer by residents and fellows.
6️⃣ ASTRO Residents/Fellows Seed Grant – $50K (1 yr) | Radiation oncology projects with broad field impact.
7️⃣ ACS–ASTRO Felix Feng Clinician Scientist Award – $729K (3–5 yrs) | Supporting practicing radiation oncologists in transformative research.
8️⃣ SWOG/Hope Foundation Impact Award – Up to $250K (2 yrs) | High-impact studies leveraging SWOG trials and data.
9️⃣ AACR Anna D. Barker Basic Cancer Research Fellowship – $110K (2 yrs) | Postdoctoral/clinical fellows in basic cancer research.
🔟 AACR–QuadW Sarcoma Research Fellowship – $60K (1 yr) | Translational and clinical sarcoma projects with patient impact.

📅 Key Deadlines: October 2025 – March 2026 (check details per grant).

🔗 Explore OncoGrants by OncoDaily – your go-to for fellowships, deadlines and direct links: https://t.co/iVzO4vIidZ

@ASTRO_org @aapmHQ @LUNGevity

#Oncogrants #CancerResearch #Oncology #ClinicalTrials #CancerCare #RadiationOncology #Immunotherapy #Leukemia #Lymphoma #ProstateCancer #LungCancer #Sarcoma #OncoDaily #Cancer

[OncoDaily @oncodaily]

🏆 𝟭𝟬𝟬 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐭𝐢𝐚𝐥 𝐏𝐞𝐨𝐩𝐥𝐞 𝐢𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝟮𝟬𝟮𝟱 – 𝐍𝐨𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐫𝐞 𝐎𝐩𝐞𝐧!

𝐖𝐞𝐥𝐜𝐨𝐦𝐞 𝐭𝐨 𝐎𝐧𝐜𝐨𝐃𝐚𝐢𝐥𝐲’𝐬 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥 𝐧𝐨𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫𝐦 𝐟𝐨𝐫 𝟭𝟬𝟬 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐭𝐢𝐚𝐥 𝐏𝐞𝐨𝐩𝐥𝐞 𝐢𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝟮𝟬𝟮𝟱 𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐛𝐲 𝐁𝐈𝐆𝐑, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

• 100 Key Opinion Leaders (KOLs) in Oncology in 2025
• 100 Oncology CEOs in 2025
• 100 Innovators in Oncology 2025
• Rising Stars in Oncology 2025

We invite you to nominate outstanding individuals who are shaping the future of oncology through leadership, research, clinical excellence, innovation, mentorship, or advocacy.

𝘌𝘢𝘤𝘩 𝘕𝘰𝘮𝘪𝘯𝘢𝘵𝘪𝘰𝘯 𝘔𝘶𝘴𝘵 𝘐𝘯𝘤𝘭𝘶𝘥𝘦:

• Supporting statement (max 250 words)
• Nominee’s social media handles/links

𝘌𝘭𝘪𝘨𝘪𝘣𝘪𝘭𝘪𝘵𝘺 𝘤𝘳𝘪𝘵𝘦𝘳𝘪𝘢:

• Individuals actively contributing to oncology or cancer care, including physicians, researchers, nurses, advocates, survivors, organizational leaders

• Must have some presence on social media (LinkedIn, Twitter/X, etc.)

• Submissions must be made before November 15, 11PM ET

Remember, you are welcome to nominate yourself!

📢 𝐒𝐔𝐁𝐌𝐈𝐒𝐒𝐈𝐎𝐍 𝐃𝐄𝐀𝐃𝐋𝐈𝐍𝐄: 𝐍𝐎𝐕𝐄𝐌𝐁𝐄𝐑 𝟭𝟱, 𝟭𝟭 𝐏𝐌 𝐄𝐓

𝐏𝐥𝐞𝐚𝐬𝐞 𝐧𝐨𝐭𝐞: Submissions made after the deadline and/or without the required materials will not be considered.

𝐍𝐨𝐦𝐢𝐧𝐚𝐭𝐞 𝐍𝐎𝐖 👇

https://t.co/K0LiSxqjfi

#Xfluencers #KOLs #100InfluentialPeopleInOncology #OncoDaily100 #cancer #oncology #OncoDaily

[OncoDaily @oncodaily]

Muscle-Invasive Bladder Cancer: Therapy Advances and Access in Turkey

Muscle-invasive bladder cancer (MIBC) is one of the most aggressive urologic cancers and the 4th most common cancer in men in Turkey. While immunotherapy, antibody-drug conjugates, and targeted therapies have redefined global standards, access gaps in Turkey-from high drug costs to limited reimbursement-still prevent many patients from benefiting.

This new review by Muharrem Coşkunpınar, Evren Süer, and Yüksel Ürün explores evolving therapies and the real-world challenges of delivering equitable care.

https://t.co/ZVRUXCgIuD

@mcpinar @DrYukselUrun

#Cancer #Medicine #Health #Oncology #OncoDaily #BladderCancer #CancerResearch #CancerTreatment #MedX #MedNews #MedEd

[OncoDaily @oncodaily]

Pediatric Neuro-Oncology in Pakistan: PNOS 2025 abstracts now published on the OncoDaily Medical Journal

The full collection of peer-reviewed abstracts from the 6th Annual Pakistan Pediatric Neuro-Oncology Symposium (PNOS 2025) hosted by Aga Khan University is now live on the OncoDaily Medical Journal.

This open collection highlights emerging data and practice insights across pediatric brain tumors - from diagnostics and molecular pathology to surgery, radiation oncology, chemotherapy, survivorship, and supportive care in resource-limited settings.

🔗 Read the abstracts: https://t.co/hb1QWte9TF

https://t.co/oJ5Ya2tW0q

@oncodaily @shhovsepyan @AKUGlobal @WorldSIOP

#PediatricNeuroOncology #PediatricOncology #NeuroOncology #BrainTumors #ChildhoodCancer #GlobalOncology #LMIC #OncoDaily #OncoDailyMedicalJournal #Pakistan #AgaKhanUniversity #RadiationOncology #Neurosurgery #PedsHemeOnc

[Amalya Sargsyan @amalsargsyan]

Finally got my @NIH reply after 2.5 years: REJECTED❌

Cute timing- but my study’s already FUNDED COMPLETED & PUBLISHED in @JCOGO_ASCO

Appreciate the reply - but oncology runs faster. You don’t🐢🚀

Full👇Nationwide Insights on Immunotherapy in Armenia https://t.co/vhecKpUvMB

[Muharrem Coşkunpınar @mcpinar]

New publication alert 📢

Our review, just published in the @oncodaily Medical Journal, highlights the widening gap between innovation and access in MIBC treatment — with a particular focus on real-world barriers in Turkey.

✒️ I’m honored that my first academic publication in oncology addresses such a clinically and globally relevant topic. I sincerely thank my mentor Prof. @DrYukselUrun for his invaluable guidance and continued support throughout this process.

📄 Read more: https://t.co/f9cJpulBcD
🔗 DOI: 10.69690/odmj‑002‑0912‑5113

@oncodaily @OncoAlert

[OncoDaily @oncodaily]

Empowering Oncologists with host Jasmine Kamboj (@JasmineKambojMD) welcomes Dr. Robin Zon (@RobinZo23059606) - Immediate Past President of American Society of Clinical Oncology (@ASCO) - for a candid, uplifting conversation on turning knowledge into action through technology, advocacy, and community.

From ASCO Edge to state-society road trips (including a wild Alaska snowstorm!), Dr. Zon shares practical playbooks for busy clinicians and why oncology remains a journey of hope and healing.

https://t.co/rtANBSzhV8

#Cancer #Oncology #OncoDaily #Health #Medicine @CancerWorldmag

[OncoDaily @oncodaily]

🌍 WCLC 2025 Highlights: FLAURA2 trial

The #FLAURA2 trial has delivered promising results. Combining osimertinib + chemotherapy in 1L EGFRm NSCLC patients leads to the longest OS ever reported in a global phase 3 EGFR trial.

@StephenVLiu @dplanchard @RManochakian @DrJNaidoo @jillfeldman4 @lungoncdoc @LuisRaezMD @diegoadiazg @SuyogCancer @esenthil84 @LUNGevity @CharuAggarwalMD @Alfdoc2 @AmitKulkarniMD @ACortelliniMD @Joshua_Reuss @Tony_Calles @JordiRemon @JulienMazieres @AnaVManana @SWaliany @bmassutis @LuisLara_M @Krishnaveni_Y

🔗 https://t.co/etJNioi5HX

#FLAURA2 #WCLC25 #LungCancer #Oncology #Health #Medicine @CancerWorldmag

[OncoDaily @oncodaily]

10 Leading Experts Join OncoDaily Journal Editorial Team

@RaeesTonse @MulaHussain @PasqualePisapia @lucianomuttihot @JyotiMalhotraMD @pankajpanda86

https://t.co/MRAM534bE9

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews @CancerWorldmag